Description

Synergistic Growth Factor Research: CJC-1295 No DAC & Ipamorelin

At GLP1 Peptides, we offer this meticulously formulated blend to support advanced endocrine and metabolic research. The CJC-1295 No DAC 5mg + Ipamorelin 5mg combination is specifically engineered to investigate the amplified response of growth hormone pathways when targeted by multiple signaling mechanisms.

By combining a GHRH (Growth Hormone Releasing Hormone) analog with a Ghrelin mimetic (GHS), researchers can observe a more physiological “pulse” of growth hormone secretion compared to single-compound administration.

The GLP1 Peptides Quality Standard

• Verified 99% Purity: Each component of the CJC-1295 No DAC 5mg + Ipamorelin 5mg blend is individually tested via HPLC and Mass Spectrometry to ensure a purity rating of 99% or higher.

• Advanced Lyophilization: Our professional freeze-drying process stabilizes the delicate peptide bonds of both compounds, ensuring long-term shelf stability and reliability for laboratory use.

• Analytical Transparency: We provide a comprehensive Certificate of Analysis (COA) with every shipment. We believe technical transparency is the foundation of credible scientific outcomes.

• Precise 1:1 Formulation: Our laboratory ensures exact milligram distribution within each vial to maintain experimental consistency across all research trials.

Technical Product Specifications:

• Components: CJC-1295 (No DAC) + Ipamorelin

• Vial Concentration: 10mg Total (5mg CJC-1295 / 5mg Ipamorelin)

• Format: White Lyophilized Powder

• Purity Rating: >99%

• Storage: Store at -20°C for optimal long-term stability and potency.